The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Contract Dose Manufacturing Market Research Report 2024
Synopsis
A contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.
The global Contract Dose Manufacturing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Contract Dose Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Contract Dose Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Contract Dose Manufacturing in Pharmaceutical Company is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Contract Dose Manufacturing include Lonza, Catalent, Aenova, Siegfried, Recipharm, Strides Shasun, Piramal, Metrics Contract Services and AMRI, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Contract Dose Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contract Dose Manufacturing.
Report Scope
The Contract Dose Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contract Dose Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contract Dose Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Catalent
Aenova
Siegfried
Recipharm
Strides Shasun
Piramal
Metrics Contract Services
AMRI
Famar
WuXi AppTech
Asymchem
Porton
Amatsigroup(Eurofins)
Thermo Fisher Scientific
Piramal Pharma Solutions
AbbVie Contract Manufacturing
Baxter BioPharma Solutions
Fareva
NextPharma
Emergent BioSolution
Segment by Type
API Development
Manufacturing
Drug Delivery
Others
Segment by Application
Pharmaceutical Company
Biotechnology Company
Generic Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Contract Dose Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.
The global Contract Dose Manufacturing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Contract Dose Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Contract Dose Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Contract Dose Manufacturing in Pharmaceutical Company is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Contract Dose Manufacturing include Lonza, Catalent, Aenova, Siegfried, Recipharm, Strides Shasun, Piramal, Metrics Contract Services and AMRI, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Contract Dose Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contract Dose Manufacturing.
Report Scope
The Contract Dose Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contract Dose Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contract Dose Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Catalent
Aenova
Siegfried
Recipharm
Strides Shasun
Piramal
Metrics Contract Services
AMRI
Famar
WuXi AppTech
Asymchem
Porton
Amatsigroup(Eurofins)
Thermo Fisher Scientific
Piramal Pharma Solutions
AbbVie Contract Manufacturing
Baxter BioPharma Solutions
Fareva
NextPharma
Emergent BioSolution
Segment by Type
API Development
Manufacturing
Drug Delivery
Others
Segment by Application
Pharmaceutical Company
Biotechnology Company
Generic Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Contract Dose Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Contract Dose Manufacturing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 API Development
1.2.3 Manufacturing
1.2.4 Drug Delivery
1.2.5 Others
1.3 Market by Application
1.3.1 Global Contract Dose Manufacturing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Generic Company
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Contract Dose Manufacturing Market Perspective (2019-2030)
2.2 Contract Dose Manufacturing Growth Trends by Region
2.2.1 Global Contract Dose Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Contract Dose Manufacturing Historic Market Size by Region (2019-2024)
2.2.3 Contract Dose Manufacturing Forecasted Market Size by Region (2025-2030)
2.3 Contract Dose Manufacturing Market Dynamics
2.3.1 Contract Dose Manufacturing Industry Trends
2.3.2 Contract Dose Manufacturing Market Drivers
2.3.3 Contract Dose Manufacturing Market Challenges
2.3.4 Contract Dose Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Contract Dose Manufacturing Players by Revenue
3.1.1 Global Top Contract Dose Manufacturing Players by Revenue (2019-2024)
3.1.2 Global Contract Dose Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Contract Dose Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Contract Dose Manufacturing Revenue
3.4 Global Contract Dose Manufacturing Market Concentration Ratio
3.4.1 Global Contract Dose Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Contract Dose Manufacturing Revenue in 2023
3.5 Contract Dose Manufacturing Key Players Head office and Area Served
3.6 Key Players Contract Dose Manufacturing Product Solution and Service
3.7 Date of Enter into Contract Dose Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Contract Dose Manufacturing Breakdown Data by Type
4.1 Global Contract Dose Manufacturing Historic Market Size by Type (2019-2024)
4.2 Global Contract Dose Manufacturing Forecasted Market Size by Type (2025-2030)
5 Contract Dose Manufacturing Breakdown Data by Application
5.1 Global Contract Dose Manufacturing Historic Market Size by Application (2019-2024)
5.2 Global Contract Dose Manufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Contract Dose Manufacturing Market Size (2019-2030)
6.2 North America Contract Dose Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Contract Dose Manufacturing Market Size by Country (2019-2024)
6.4 North America Contract Dose Manufacturing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Contract Dose Manufacturing Market Size (2019-2030)
7.2 Europe Contract Dose Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Contract Dose Manufacturing Market Size by Country (2019-2024)
7.4 Europe Contract Dose Manufacturing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Contract Dose Manufacturing Market Size (2019-2030)
8.2 Asia-Pacific Contract Dose Manufacturing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Contract Dose Manufacturing Market Size by Region (2019-2024)
8.4 Asia-Pacific Contract Dose Manufacturing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Contract Dose Manufacturing Market Size (2019-2030)
9.2 Latin America Contract Dose Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Contract Dose Manufacturing Market Size by Country (2019-2024)
9.4 Latin America Contract Dose Manufacturing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Contract Dose Manufacturing Market Size (2019-2030)
10.2 Middle East & Africa Contract Dose Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Contract Dose Manufacturing Market Size by Country (2019-2024)
10.4 Middle East & Africa Contract Dose Manufacturing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Contract Dose Manufacturing Introduction
11.1.4 Lonza Revenue in Contract Dose Manufacturing Business (2019-2024)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Detail
11.2.2 Catalent Business Overview
11.2.3 Catalent Contract Dose Manufacturing Introduction
11.2.4 Catalent Revenue in Contract Dose Manufacturing Business (2019-2024)
11.2.5 Catalent Recent Development
11.3 Aenova
11.3.1 Aenova Company Detail
11.3.2 Aenova Business Overview
11.3.3 Aenova Contract Dose Manufacturing Introduction
11.3.4 Aenova Revenue in Contract Dose Manufacturing Business (2019-2024)
11.3.5 Aenova Recent Development
11.4 Siegfried
11.4.1 Siegfried Company Detail
11.4.2 Siegfried Business Overview
11.4.3 Siegfried Contract Dose Manufacturing Introduction
11.4.4 Siegfried Revenue in Contract Dose Manufacturing Business (2019-2024)
11.4.5 Siegfried Recent Development
11.5 Recipharm
11.5.1 Recipharm Company Detail
11.5.2 Recipharm Business Overview
11.5.3 Recipharm Contract Dose Manufacturing Introduction
11.5.4 Recipharm Revenue in Contract Dose Manufacturing Business (2019-2024)
11.5.5 Recipharm Recent Development
11.6 Strides Shasun
11.6.1 Strides Shasun Company Detail
11.6.2 Strides Shasun Business Overview
11.6.3 Strides Shasun Contract Dose Manufacturing Introduction
11.6.4 Strides Shasun Revenue in Contract Dose Manufacturing Business (2019-2024)
11.6.5 Strides Shasun Recent Development
11.7 Piramal
11.7.1 Piramal Company Detail
11.7.2 Piramal Business Overview
11.7.3 Piramal Contract Dose Manufacturing Introduction
11.7.4 Piramal Revenue in Contract Dose Manufacturing Business (2019-2024)
11.7.5 Piramal Recent Development
11.8 Metrics Contract Services
11.8.1 Metrics Contract Services Company Detail
11.8.2 Metrics Contract Services Business Overview
11.8.3 Metrics Contract Services Contract Dose Manufacturing Introduction
11.8.4 Metrics Contract Services Revenue in Contract Dose Manufacturing Business (2019-2024)
11.8.5 Metrics Contract Services Recent Development
11.9 AMRI
11.9.1 AMRI Company Detail
11.9.2 AMRI Business Overview
11.9.3 AMRI Contract Dose Manufacturing Introduction
11.9.4 AMRI Revenue in Contract Dose Manufacturing Business (2019-2024)
11.9.5 AMRI Recent Development
11.10 Famar
11.10.1 Famar Company Detail
11.10.2 Famar Business Overview
11.10.3 Famar Contract Dose Manufacturing Introduction
11.10.4 Famar Revenue in Contract Dose Manufacturing Business (2019-2024)
11.10.5 Famar Recent Development
11.11 WuXi AppTech
11.11.1 WuXi AppTech Company Detail
11.11.2 WuXi AppTech Business Overview
11.11.3 WuXi AppTech Contract Dose Manufacturing Introduction
11.11.4 WuXi AppTech Revenue in Contract Dose Manufacturing Business (2019-2024)
11.11.5 WuXi AppTech Recent Development
11.12 Asymchem
11.12.1 Asymchem Company Detail
11.12.2 Asymchem Business Overview
11.12.3 Asymchem Contract Dose Manufacturing Introduction
11.12.4 Asymchem Revenue in Contract Dose Manufacturing Business (2019-2024)
11.12.5 Asymchem Recent Development
11.13 Porton
11.13.1 Porton Company Detail
11.13.2 Porton Business Overview
11.13.3 Porton Contract Dose Manufacturing Introduction
11.13.4 Porton Revenue in Contract Dose Manufacturing Business (2019-2024)
11.13.5 Porton Recent Development
11.14 Amatsigroup(Eurofins)
11.14.1 Amatsigroup(Eurofins) Company Detail
11.14.2 Amatsigroup(Eurofins) Business Overview
11.14.3 Amatsigroup(Eurofins) Contract Dose Manufacturing Introduction
11.14.4 Amatsigroup(Eurofins) Revenue in Contract Dose Manufacturing Business (2019-2024)
11.14.5 Amatsigroup(Eurofins) Recent Development
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Detail
11.15.2 Thermo Fisher Scientific Business Overview
11.15.3 Thermo Fisher Scientific Contract Dose Manufacturing Introduction
11.15.4 Thermo Fisher Scientific Revenue in Contract Dose Manufacturing Business (2019-2024)
11.15.5 Thermo Fisher Scientific Recent Development
11.16 Piramal Pharma Solutions
11.16.1 Piramal Pharma Solutions Company Detail
11.16.2 Piramal Pharma Solutions Business Overview
11.16.3 Piramal Pharma Solutions Contract Dose Manufacturing Introduction
11.16.4 Piramal Pharma Solutions Revenue in Contract Dose Manufacturing Business (2019-2024)
11.16.5 Piramal Pharma Solutions Recent Development
11.17 AbbVie Contract Manufacturing
11.17.1 AbbVie Contract Manufacturing Company Detail
11.17.2 AbbVie Contract Manufacturing Business Overview
11.17.3 AbbVie Contract Manufacturing Contract Dose Manufacturing Introduction
11.17.4 AbbVie Contract Manufacturing Revenue in Contract Dose Manufacturing Business (2019-2024)
11.17.5 AbbVie Contract Manufacturing Recent Development
11.18 Baxter BioPharma Solutions
11.18.1 Baxter BioPharma Solutions Company Detail
11.18.2 Baxter BioPharma Solutions Business Overview
11.18.3 Baxter BioPharma Solutions Contract Dose Manufacturing Introduction
11.18.4 Baxter BioPharma Solutions Revenue in Contract Dose Manufacturing Business (2019-2024)
11.18.5 Baxter BioPharma Solutions Recent Development
11.19 Fareva
11.19.1 Fareva Company Detail
11.19.2 Fareva Business Overview
11.19.3 Fareva Contract Dose Manufacturing Introduction
11.19.4 Fareva Revenue in Contract Dose Manufacturing Business (2019-2024)
11.19.5 Fareva Recent Development
11.20 NextPharma
11.20.1 NextPharma Company Detail
11.20.2 NextPharma Business Overview
11.20.3 NextPharma Contract Dose Manufacturing Introduction
11.20.4 NextPharma Revenue in Contract Dose Manufacturing Business (2019-2024)
11.20.5 NextPharma Recent Development
11.21 Emergent BioSolution
11.21.1 Emergent BioSolution Company Detail
11.21.2 Emergent BioSolution Business Overview
11.21.3 Emergent BioSolution Contract Dose Manufacturing Introduction
11.21.4 Emergent BioSolution Revenue in Contract Dose Manufacturing Business (2019-2024)
11.21.5 Emergent BioSolution Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
